Skip to main content

Table 4 Clinical features and pregnancy outcomes in the deficiency and adequate groups

From: 25(OH)D3 improves granulosa cell proliferation and IVF pregnancy outcomes in patients with endometriosis by increasing G2M+S phase cells

Group

Sufficient group(≥ 20 ug/ml)

Deficiency group (< 20 ug/ml)

Age (years)

30.59 ± 3.554

30.93 ± 3.957

BMI(kg/m2)

22.25 ± 3.436

23.26 ± 4.750

History of adverse pregnancy (times)

1.00(0.00,1.00)

0.00(0.00,1.00)

Infertility years (years)

3.00(2.00,5.50)

4.00(2.00,5.25)

Assisted reproduction history (times)

0.00(0.00,1.00)

1.00(0.00,2.00)

FSH(U/L)

7.2(5.95,8.1)

6.25(5.10, 8.40)

LH(U/L)

5.5(4.25.7.05)

4.75(3.25,7.23)

E2(pg/mL)

34.00(27.00,40.80)

39.25(21.30,51.45)

AMH(ng/mL)

2.03(1.44,3.49)

1.83(1.18,2.81)

P(ng/mL)

0.30(0.20,0.35)

0.30(0.11,0.40)

PRL(ng/mL)

20.00(17.30,29.30)

19.00(14.23,27.35)

Number of eggs harvested

21.3(15.4,26.75)

17.5(11.00,25.05)

MII rate(%)

85.3(284/333)

82.7(706/854)

High quality embryo rate(%)

47.4(55/116)

33.3(92/276)*

Number of transplantable embryos

5.00(5.00,8.5)

4.00(2.75,6.00)*

Number of transplanted embryos

1.00(1.00,2.00)

1.00(1.00,2.00)

Endometrial thickness at the day of embryo transfer (mm)

10.00(9.125,11.750)

10.00(9.00,11.00)

Clinical pregnancy rate (%)

82.4(14/17)

51.7(30/58)*

Abortion rate (%)

14.3(2/14)

6.67(2/30)

Ectopic pregnancy rate (%)

0.00(0/14)

6.67(2/30)

Live birth rate (%)

70.6(12/17)

44.8(26/58)

  1. *p < 0.05